sprite-preloader
Anzeige
Mehr »
Montag, 24.09.2018 Börsentäglich über 12.000 News von 597 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrMedical & Scientific Excellence Awards - Have you entered yet?
Fr2018 PM Society Digital Awards winners announced
FrABPI enters five-year partnership with AHSN
FrCelgene walks away from Oncomed's navicixizumab
FrDaiichi to test cancer drug combo
DoDomainex appoints Dr Trevor Perrior as CEO
DoCR UK forms £30m partnership with EU cancer charities
DoSetback for Pharming's bid to expand use of Ruconest
DoEU green light for new Humira biosimilar
DoAstellas' kidney disease drug shows promise in PhIII
DoAddex joins UK drug and brain research initiative
MiNorgine buys rights to sell Shield's iron deficiency therapy
MiNICE rejects Novartis' CAR-T Kymriah for adult lymphoma
MiAI drug discovery platform gets £1m innovation boost
MiThe number of children being vaccinated in England falls again
MiAlmirall steps into psoriasis market with Ilumetri approval
MiActelion's Opsumit shows promise in portopulmonary hypertension
DiAllergan, Sosei suspend clinical development of dementia drug
DiAstraZeneca' Fasenra shows long-term efficacy in eosinophilic asthma
DiCR UK invests £14m in London cancer biotherapeutics hub
DiInnovate UK gives £1 million to AI project
DiNew study to explore genetic links to depression and anxiety
17.09.Allergan snaps up Bonti
17.09.NICE nod for Novartis' targeted skin cancer combo
17.09.Teva's anti-CGRP drug Ajvoy cleared for migraine prevention